Cover Image
Market Research Report
Product code 
1063690

Acute Migraine Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

Published: | Infinium Global Research (IGR) | 100 Pages | Delivery time: 1-2 business days

Price

Back to Top
Acute Migraine Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027
Published: February 10, 2022
Infinium Global Research (IGR)
Content info: 100 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

The report on the global acute migraine drugs market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global acute migraine drugs market to grow with a CAGR of 7% over the forecast period from 2021-2027. The study on acute migraine drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on acute migraine drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global acute migraine drugs market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global acute migraine drugs market over the period of 2019 to 2027. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Increasing demand for quality drugs
  • Rising incidence of migraine among People

2) Restraints

  • Side effects of migraine drugs
  • Stringent government rules and regulations

3) Opportunities

  • The introduction of novel therapies on the treatment of migraine will act as an opportunity for the acute migraine drug market.

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global acute migraine drugs market is segmented on the basis of drug, application, and distribution channel.

The Global Acute Migraine Drugs Market by Drug

  • Abortive Medicine
  • Preventive Medicine

The Global Acute Migraine Drugs Market by Application

  • Oral
  • Injectable
  • Nasal Sprays

The Global Acute Migraine Drugs Market by Distribution Channel

  • Hospital-based Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Company Profiles

The companies covered in the report include

  • Endo Pharmaceuticals Inc
  • Allergan
  • Impax Laboratories
  • Glaxo Smith Kline
  • Astellas
  • Amgen
  • Bayer
  • AstraZeneca
  • Dr. Reddy's Laboratories
  • Zogenix

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the acute migraine drugs market.

2. Complete coverage of all the segments in the acute migraine drugs market to analyze the trends, developments in the global market and forecast of market size up to 2027.

3. Comprehensive analysis of the companies operating in the global acute migraine drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Product Code: HC08736

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Acute Migraine Drugs Market Highlights
  • 2.2. Acute Migraine Drugs Market Projection
  • 2.3. Acute Migraine Drugs Market Regional Highlights

3. Global Acute Migraine Drugs Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Acute Migraine Drugs Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Drug
    • 3.5.2. IGR-Growth Matrix Analysis by Application
    • 3.5.3. IGR-Growth Matrix Analysis by Distribution Channel
    • 3.5.4. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Acute Migraine Drugs Market

4. Acute Migraine Drugs Market Macro Indicator Analysis

5. Global Acute Migraine Drugs Market by Drug

  • 5.1. Abortive Medicine
  • 5.2. Preventive Medicine

6. Global Acute Migraine Drugs Market by Application

  • 6.1. Oral
  • 6.2. Injectable
  • 6.3. Nasal Sprays

7. Global Acute Migraine Drugs Market by Distribution Channel

  • 7.1. Hospital-based Pharmacies
  • 7.2. Retail Pharmacies
  • 7.3. Online Pharmacies

8. Global Acute Migraine Drugs Market by Region 2021-2027

  • 8.1. North America
    • 8.1.1. North America Acute Migraine Drugs Market by Drug
    • 8.1.2. North America Acute Migraine Drugs Market by Application
    • 8.1.3. North America Acute Migraine Drugs Market by Distribution Channel
    • 8.1.4. North America Acute Migraine Drugs Market by Country
  • 8.2. Europe
    • 8.2.1. Europe Acute Migraine Drugs Market by Drug
    • 8.2.2. Europe Acute Migraine Drugs Market by Application
    • 8.2.3. Europe Acute Migraine Drugs Market by Distribution Channel
    • 8.2.4. Europe Acute Migraine Drugs Market by Country
  • 8.3. Asia-Pacific
    • 8.3.1. Asia-Pacific Acute Migraine Drugs Market by Drug
    • 8.3.2. Asia-Pacific Acute Migraine Drugs Market by Application
    • 8.3.3. Asia-Pacific Acute Migraine Drugs Market by Distribution Channel
    • 8.3.4. Asia-Pacific Acute Migraine Drugs Market by Country
  • 8.4. RoW
    • 8.4.1. RoW Acute Migraine Drugs Market by Drug
    • 8.4.2. RoW Acute Migraine Drugs Market by Application
    • 8.4.3. RoW Acute Migraine Drugs Market by Distribution Channel
    • 8.4.4. RoW Acute Migraine Drugs Market by Sub-region

9. Company Profiles and Competitive Landscape

  • 9.1. Competitive Landscape in the Global Acute Migraine Drugs Market
  • 9.2. Companies Profiles
    • 9.2.1. Endo Pharmaceuticals Inc
    • 9.2.2. Allergan
    • 9.2.3. Impax Laboratories
    • 9.2.4. Glaxo Smith Kline
    • 9.2.5. Astellas
    • 9.2.6. Amgen
    • 9.2.7. Bayer
    • 9.2.8. AstraZeneca
    • 9.2.9. Dr. Reddy's Laboratories
    • 9.2.10. Zogenix